Clin2
NCT05024292Possibly a fitRecruiting

Alliance study for acute stroke after clot removal

Ischemic Stroke

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests a stroke treatment plan for adults after they have a clot removed by a catheter procedure (endovascular treatment). It focuses on people with certain artery blockages and specific scan results, aiming to improve recovery after successful clot removal.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
160 people
Ages
18 years to 95 years
Study type
Observational

Who can take part

  • You are an adult (age 18 to 95)
  • Your stroke was caused by a blocked internal carotid artery or middle brain artery (M1 or M2)
  • At the hospital, your stroke severity was moderately severe (NIHSS at least 6), and you were mostly independent before the stroke (modified Rankin 0–1)
  • Your brain CT scan scores meet thresholds (NIHSS/ASPECTS requirements) and you had special scans (NCCT, CTA, and CTP) at the trial site hospital
  • After the last clot-removal attempt, the artery reopening was successful (mTICI 2b to 3)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06940128Recruiting
Ischemic conditioning after stroke clot removal

This trial tests a method called direct ischemic conditioning, which is a gentle way to prepare your brain to better handle the return of blood flow after a stroke. It is for people who have had a large artery blockage in the front part of the brain and have already had a successful procedure to reopen the artery.

Shengyang, Liaoning
NCT07367100Recruiting
Testing a new clot-removal catheter for stroke

This study tests a special catheter (a thin tube) designed to remove blood clots from large arteries in the brain during a stroke. The goal is to see if it is safe and effective at restoring blood flow.

Edegem
NCT06949228Recruiting· Phase 2/Phase 3
Intra-Arterial Tenecteplase After Clot Removal for Stroke

This trial tests whether giving a clot-busting drug called tenecteplase directly into the brain artery after a successful mechanical clot removal can improve recovery for people with a certain type of stroke. The goal is to see if it safely helps clear any remaining tiny clots and reduces disability.

Toledo, Ohio
NCT07495969Not yet recruiting
Study of reopening blocked arteries in the brain to prevent stroke

This trial tests if a procedure to reopen a blocked brain artery can help people who have had mini-strokes or strokes despite medical treatment. It is for people with a blockage in a specific brain artery that happened 2 weeks to 3 months ago.

Beijing, Beijing Municipality
NCT07476898Not yet recruiting· Phase 3
Precision clot treatment for disabling minor stroke with large vessel blockage beyond time window

This trial tests a specialized clot-removal treatment for people who had a mild but disabling stroke up to 24 hours ago and have a large artery blockage in the brain. The goal is to see if this precision therapy can help reduce disability and improve recovery.

Fuzhou, Fujian
NCT07598799Not yet recruiting
Testing a recovery technique after stroke clot removal

This trial tests whether a special blood-flow technique applied right after removing a clot from your brain artery can help you recover better from stroke. You would receive this treatment during your clot-removal procedure if you qualify.

Hear when a new Ischemic Stroke trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.